Consolidated Investment Group Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$14.2M |
| 2 |
CVS Health
CVS
|
+$3.83M |
| 3 |
ABB
ABB Ltd
ABB
|
+$3.24M |
| 4 |
VanEck Biotech ETF
BBH
|
+$2.92M |
| 5 |
Chevron
CVX
|
+$2.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lockheed Martin
LMT
|
+$5.58M |
| 2 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$2.24M |
| 3 |
HealthEquity
HQY
|
+$1.68M |
| 4 |
VF Corp
VFC
|
+$1.41M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$615K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.91% |
| 2 | Financials | 14.24% |
| 3 | Consumer Discretionary | 7.56% |
| 4 | Healthcare | 6.42% |
| 5 | Communication Services | 4.98% |
Similar funds
Consolidated Investment Group's Q1 2022 Portfolio in Review
As of Q1 2022, Consolidated Investment Group held 81 positions worth $613M, down 2.8% from $631M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Consolidated Investment Group deployed $30.8M of net new capital in Q1 2022, opening 7 new positions and adding to 18 existing holdings. Its largest new stake was ABB Ltd: 92,800 shares worth $3M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the most notable exit was Lockheed Martin, an estimated $5.58M sold.
- Consolidated Investment Group's largest Q1 2022 buy was ABB Ltd: 92,800 shares worth $3M.
- Consolidated Investment Group added most to Invesco QQQ Trust in Q1 2022, an estimated $14.2M increase.
- Consolidated Investment Group fully exited Lockheed Martin in Q1 2022, selling an estimated $5.58M.
- Consolidated Investment Group's ten largest holdings make up 53% of its $613M portfolio in Q1 2022.
- Consolidated Investment Group opened 7 new positions and closed 6 in Q1 2022.
- Consolidated Investment Group's portfolio value fell 2.8% quarter-over-quarter to $613M.
Based on Consolidated Investment Group's 13F filing for Q1 2022, filed 28 Apr 2022.